Cargando…
Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life
Erythrodermic mycosis fungoides and Sézary syndrome are chronic, relapsing‐remitting diseases that greatly impacts patients' quality of life (QoL). Mogamulizumab‐kpkc (Mogamulizumab) is a novel therapeutic agent for cutaneous T‐cell lymphomas with a notable impact on progression‐free survival....
Autores principales: | Ottevanger, Rosanne, Feenstra, Judith S., van Vliet, Liesbeth M., van Beugen, Sylvia, Evers, Andrea W. M., Kennedy, Cees, Willemze, Rein, Vermeer, Maarten H., Quint, Koen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690699/ https://www.ncbi.nlm.nih.gov/pubmed/38047257 http://dx.doi.org/10.1002/ski2.300 |
Ejemplares similares
-
Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator
por: Ottevanger, Rosanne, et al.
Publicado: (2022) -
Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
por: Ottevanger, Rosanne, et al.
Publicado: (2022) -
Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”
por: Ottevanger, Rosanne, et al.
Publicado: (2022) -
Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature
por: Ottevanger, R., et al.
Publicado: (2021) -
Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients
por: van Santen, Suzanne, et al.
Publicado: (2019)